FABHALTA (iptacopan) capsules

FABHALTA is a prescription medicine used to treat paroxysmal nocturnal hemoglobinuria (PNH) and primary immunoglobulin. FDA approved iptacopan (brand name FABHALTA) is not (yet) registered or available in India but on request Indian patient can buy FABHALTA at the lowest price.

FABHALTA-iptacopan-Price-Delhi-India
FABHALTA (iptacopan) capsules

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

FABHALTA (iptacopan) capsules

It is also indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. In

FABHALTA is a prescription medicine used to treat adults with a disease called paroxysmal nocturnal hemoglobinuria
(PNH).

Iptacopan, sold under the brand name Fabhalta, is a medication used for the treatment of paroxysmal nocturnal hemoglobinuria and proteinuria. It is a complement factor B inhibitor that was developed by Novartis.

Iptacopan was approved for medical use in the United States in December 2023, and in the European Union in May 2024. The US Food and Drug Administration considers it to be a first-in-class medication.

FABHALTA (iptacopan) capsules, for oral use Initial U.S. Approval: 2023
—————-
Current Indication: Treat t of adults with paroxysmal nocturnal hemoglobinuria (PNH)
—————-
Marketed By: t Novartis Pharmaceuticals Corporation
—————-
Approval Date: : 2023
—————-
Active ingredient: iptacopan
—————-
Inactive ingredients: the capsule shell contains gelatin, red ferric oxide, titanium dioxide, yellow ferric oxide. The
black printing ink contains ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, and strong ammonia
solution.
———————

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.